Cowen And Company »

Somalogic shares owned by Cowen And Company

Quarter-by-quarter ownership of Somalogic shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Somalogic

Tip: Access up to 7 years of quarterly data

All positions including Somalogic held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Somalogic by Cowen And Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $56k 468k 0.12

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Coinbase Global Com Cl A (COIN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Avidity Biosciences Ord (RNA)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ptc Therapeutics I (PTCT)
Tarsus Pharmaceuticals (TARS)
Quanta Services (PWR)
Establishment Labs Holdings Ord (ESTA)
Stoke Therapeutics (STOK)
Protagonist Therapeutics (PTGX)
Apple (AAPL)
Fulcrum Therapeutics (FULC)
Sumitomo Mitsui Finl Group I Sponsored Adr (SMFG)

View all positions for Cowen And Company

Top funds holding Somalogic

D. E. Shaw & Co
LMR Partners
CSS
Gagnon Securities
Millennium Management
Deerfield Management Company
T. Rowe Price Associates
Gagnon Advisors
Saba Capital Management
Two Sigma Investments
Fort Baker Capital Management
Jpmorgan Chase & Co
Wolverine Asset Management
TD Asset Management
Bleichroeder

View all funds holding Somalogic